Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Maintenance of Remission in Pediatric Crohn's Disease
NCT01632462Phase 4Unknown
- Sponsor
- University of Naples Federico II
- Start
- Sep 2012
- Primary completion
- Dec 2014
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Crohn's disease comparing VSL#3 First with Placebo First (2 arms). Primary endpoints: Metabolic profile at 22 weeks, Intestinal permeability at 22 weeks and 2 more. Status: unknown.
02
Drugs
VSL#3
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01632462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01632462.